These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 4672049
1. [Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes]. Ciuca I, Bulandra R, Serbanesco A, Ninosu N. Rev Neurol (Paris); 1972 Aug; 127(2):305-8. PubMed ID: 4672049 [No Abstract] [Full Text] [Related]
2. Parkinson's disease; modern treatment. Tolosa E. Minn Med; 1973 Jun; 56(6):497-502. PubMed ID: 4575903 [No Abstract] [Full Text] [Related]
3. [Current medical treatment of Parkinsonian syndromes]. Cincă I, Bulandra R, Serbănesco A, Ninosu N. Rev Roum Neurol; 1973 Jun; 10(4):257-85. PubMed ID: 4767886 [No Abstract] [Full Text] [Related]
4. [Present-day treatment of parkinsonism in the aged]. Siegfried J. Schweiz Rundsch Med Prax; 1973 Oct 02; 62(40):1202-3. PubMed ID: 4754539 [No Abstract] [Full Text] [Related]
5. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes]. Kluzer G, Lampo B. Minerva Med; 1971 Oct 31; 62(82):4013-4. PubMed ID: 5125067 [No Abstract] [Full Text] [Related]
6. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes and their implications for rehabilitation]. Raspa EG, Paciaroni E, Saccomanno G. Minerva Med; 1971 Oct 31; 62(82):4031-5. PubMed ID: 5125073 [No Abstract] [Full Text] [Related]
7. L-dopa and amantadine for Parkinsonism. Drug Ther Bull; 1970 Aug 14; 8(17):65-7. PubMed ID: 5480244 [No Abstract] [Full Text] [Related]
8. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa]. Ambrosetto C, Martinelli P. Minerva Med; 1971 Oct 31; 62(82):4017-9. PubMed ID: 5125069 [No Abstract] [Full Text] [Related]
9. [Association of L-dopa and other therapeutic methods in treatment of parkinsonian syndromes]. Mingrino S. Sist Nerv; 1970 Oct 31; 22(2):212-5. PubMed ID: 4926920 [No Abstract] [Full Text] [Related]
10. [Action of amantadine HCl alone and in combination with L-dopa on parkinsonism]. Danielczyk W, Korten JJ. Med Monatsschr; 1971 Oct 31; 25(10):472-9. PubMed ID: 5122447 [No Abstract] [Full Text] [Related]
11. Treatment of Parkinson's disease with amantadine and L-Dopa. Rinne UK, Sonninen V, Siirtola T. Eur Neurol; 1972 Oct 31; 7(4):228-40. PubMed ID: 4556618 [No Abstract] [Full Text] [Related]
12. The management of parkinsonism. N Z Med J; 1971 Jul 31; 74(470):36-7. PubMed ID: 5289750 [No Abstract] [Full Text] [Related]
13. [Attempt at treating parkinsonism with L-dopa and Artane]. Stelmasiak Z, Lackowska H, Maksymowicz B. Pol Tyg Lek; 1971 Aug 23; 26(34):1325-6. PubMed ID: 5110789 [No Abstract] [Full Text] [Related]
14. Drug therapy of parkinsonism. Yahr MD, Duvoisin RC. N Engl J Med; 1972 Jul 06; 287(1):20-4. PubMed ID: 4555145 [No Abstract] [Full Text] [Related]
15. [Treatment of Parkinson's disease with amantadine]. Sigwald J, Raymondeaud C, Grégoire J. Therapeutique; 1972 Nov 06; 48(9):555-60. PubMed ID: 4568230 [No Abstract] [Full Text] [Related]
16. [Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease]. Dzudza M, Dzudza D. Med Arh; 1974 Nov 06; 28(4):407-15. PubMed ID: 4613968 [No Abstract] [Full Text] [Related]
17. Administration of amandine to patients on optimum L-dopa dosage. Fehling C. Acta Neurol Scand Suppl; 1972 Nov 06; 51():119-20. PubMed ID: 4514335 [No Abstract] [Full Text] [Related]
18. [Factors which influence infavourably l-dopa treatment]. Presthus J. Tidsskr Nor Laegeforen; 1973 Oct 10; 93(28):2115-6. PubMed ID: 4590071 [No Abstract] [Full Text] [Related]
19. Combined L-dopa and amantadine in Parkinsonism. Pollock M, Jorgensen PB. Aust N Z J Med; 1972 Aug 10; 2(3):252-5. PubMed ID: 4564049 [No Abstract] [Full Text] [Related]
20. [Kr 339 in the treatment of parkinsonian tremor]. Iivanainen M. Duodecim; 1974 Aug 10; 90(8):590-6. PubMed ID: 4605767 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]